Bilateral Cataract after Taking Oxcarbazepine
Journal of the Korean Ophthalmological Society
;
: 486-490, 2019.
Artículo
en Coreano
| WPRIM
| ID: wpr-738626
ABSTRACT
PURPOSE:
To report a case of bilateral posterior subcapsular cataract after taking oxcarbazepine (Trileptal®, Novartis, Basel, Swiss). CASESUMMARY:
A 19-year-old female visited our clinic with decreased vision in both eyes. Her best-corrected visual acuity was 0.3 in the right eye and 0.5 in the left eye, and slit-lamp examination revealed a bilateral cortical opacity and subcapsular cataract. She had been taking oxcarbazepine for epilepsy for 10 years, which was discontinued 3 years ago. Her mother had undergone cataract surgeries when she was approximately 46 years of age. No other risk factors for cataract were present.CONCLUSIONS:
In the present case, bilateral cortical opacity and subcapsular cataract were assumed to be associated with the use of oxcarbazepine. We suggest that oxcarbazepine could induce a cataract and recommend a regular follow-up by a qualified ophthalmologist.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Catarata
/
Agudeza Visual
/
Factores de Riesgo
/
Estudios de Seguimiento
/
Epilepsia
/
Madres
Tipo de estudio:
Estudio de etiología
/
Estudio observacional
/
Estudio pronóstico
/
Factores de riesgo
Límite:
Femenino
/
Humanos
Idioma:
Coreano
Revista:
Journal of the Korean Ophthalmological Society
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS